Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by amugsgameon Jun 18, 2013 1:18pm
259 Views
Post# 21538036

Am I Missing Something

Am I Missing Something

To be upfront, my thought is to short AM based on the following :

  • company has no new business past 2014, will close plants and lay off employees
  • as others have pointed out, solid assets probably worth nil - industrial equpment has a pennies on the dollar resale value
  • residual cash value per share after wind-up of existing business about $1.85 if (big "if") they can not bleed $ in the next year (March 2013 Financials show $41 mil in cash / receivables divided by 2.2 mil shares) 
  • will management want to put themselves out of jobs or collect salaries while looking for another opportunities for AM and keep the company going?
  • AM is supposedly buying back up to 1.3 mil shares - are these being cancelled as they have in the past or sitting in the treasury for redistribution - and remember they are using cash to buy them so although saving on dividend payouts it is still a dillution of cash on hand
  • why would anyone wait for the next 1 1/2 years (minimum) to make the difference between todays price and the potential wind up value - Im sure this is a strictly retail stock at the moment

Feel free to set me right  

Bullboard Posts